Thermo Fisher Scientific Inc (TMO) concluded trading on Thursday at a closing price of $520.86, with 2.66 million shares of worth about $1.39 billion changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -10.17% during that period and on December 05, 2024 the price saw a loss of about -1.51%. Currently the company’s common shares owned by public are about 382.50M shares, out of which, 381.97M shares are available for trading.
Stock saw a price change of -0.15% in past 5 days and over the past one month there was a price change of -7.12%. Year-to-date (YTD), TMO shares are showing a performance of -1.87% which increased to 5.95% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $487.06 but also hit the highest price of $627.88 during that period. The average intraday trading volume for Thermo Fisher Scientific Inc shares is 1.59 million. The stock is currently trading -1.06% below its 20-day simple moving average (SMA20), while that difference is down -7.28% for SMA50 and it goes to -9.66% lower than SMA200.
Thermo Fisher Scientific Inc (NYSE: TMO) currently have 382.50M outstanding shares and institutions hold larger chunk of about 90.09% of that.
The stock has a current market capitalization of $199.23B and its 3Y-monthly beta is at 0.77. PE ratio of stock for trailing 12 months is 32.66, while it has posted earnings per share of $15.95 in the same period. Its PEG reads 4.76 and has Quick Ratio of 1.26 while making debt-to-equity ratio of 0.72. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TMO, volatility over the week remained 1.83% while standing at 2.14% over the month.
Stock’s fiscal year EPS is expected to rise by 0.67% while it is estimated to increase by 8.43% in next year. EPS is likely to shrink at an annualized rate of 6.87% for next 5-years, compared to annual growth of 16.37% made by the stock over the past 5-years.
Coverage by Stephens stated Thermo Fisher Scientific Inc (TMO) stock as an Overweight in their note to investors on October 01, 2024, suggesting a price target of $680 for the stock. On August 28, 2024, Wells Fargo Initiated their recommendations, while on June 03, 2024, Jefferies Resumed their ratings for the stock with a price target of $650. Stock get a Neutral rating from Citigroup on March 18, 2024.
